| NCT06258447 | CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection Fraction | RECRUITING | NA | 2024-08-01 | 2029-04-01 | 2027-04-01 |
| NCT05491681 | AllogeneiC Expanded Human MSC Therapy in Patients Recovering From COVID-19 Acute Respiratory Distress Trial | NOT_YET_RECRUITING | PHASE1 | 2024-08 | 2025-12 | 2025-08 |
| NCT05925608 | Clinical Trial of Human Allogenic Culture-expanded Bone Marrow-derived Mesenchymal Stem Cells | ENROLLING_BY_INVITATION | PHASE1, PHASE2 | 2023-08-23 | 2025-07 | 2025-07 |
| NCT03455725 | CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial | RECRUITING | NA | 2021-06-30 | 2026-12 | 2025-07 |
| NCT02438306 | CardiAMP™ Cell Therapy for Heart Failure Trial | COMPLETED | PHASE3 | 2016-12 | 2025-06 | 2025-02 |
| NCT00507468 | Autologous Bone Marrow Transplanted Via Transendocardial Catheter to Chronic Myocardial Infarct Border Zone | COMPLETED | PHASE1 | 2005-12 | 2009-08 | 2009-03 |